Archived articles

Bert vogelstein

Cancer research
New brain cancer therapy relies on Hopkins discovery
Published Aug 7, 2024
FDA-approved drug targets a mutated gene identified in 2008 by Hopkins cancer expert Bert Vogelstein and his team in collaboration with Duke researchers
Tech Ventures
Early cancer detection test gets record investment
Published June 3, 2019
CancerSEEK, pioneered at Hopkins, will be developed by a new company that launched last week with $110M in Series A funding
Cancer research
Single blood tests screens for eight common cancers
Published Jan 19, 2018
CancerSEEK is a noninvasive test that can detect cancers of the ovary, liver, stomach, pancreas, esophagus, colorectum, lung, or breast
Cancer research
Study: Random DNA errors cause majority of cancer cases
Published March 23, 2017 Video
Most cancer mutations are due to DNA copying 'mistakes,' not inherited or environmental factors, Hopkins researchers say
Analyzing cancer's causes
Published Jan 1, 2015
New findings show that random gene mutations cause two-thirds of adult cancer incidence across tissues
Keeping cancer in check
Published Dec 9, 2013
Evidence found by School of Medicine scientists may shed light on cancer origins / Hopkins Medicine
Breakthrough
Vogelstein receives $3 million life sciences award
Published Feb 20, 2013
Johns Hopkins oncologist among 11 recipients of Breakthrough Prize in Life Sciences, world's richest academic prize for medicine, biology / The New York Times